What Management Said
Read the full Q2 2026 transcript ↗Yesterday, we issued our second quarter 2026 earnings release, presentation materials, and supplemental information package, which are available on the Ventas website at ir.ventasreit.com. For more detailed discussion of those factors, please refer to our earnings release for this quarter and to our most recent SEC filings, all of which are available on the Ventas website. I'm pleased to welcome you to the Ventas second quarter 2026 earnings call. Ventas delivered excellent results in the quarter, powered by strong growth in our senior housing operating portfolio and accelerating senior housing investment activity.
SHOP led the way with 18% NOI and 360 basis points of occupancy growth year-over-year as we continue to outperform the industry. Our second quarter FFO per share of $0.97 represented 9% year-over-year growth. For the full year, we are again raising our normalized FFO expectations to $3.85-3.90 per share, equating to 8%-10% growth, primarily because of our increased investment activity. Our investment success has been enabled by the integration of our Ventas OI platform with our capital allocation decisions under Justin's leadership.
senior housing, particularly acquisitions that combine attractive growth, yield, and risk-adjusted return potential. Our investment activities and outlook, of course, are based upon the unprecedented demographic demand for senior housing. The leading edge of the nearly 70 million baby boomers has just begun turning 80 this year, ushering in a decade where the growth rate of the senior population more than doubles. With demand expected to substantially outrun supply and the persistence of elongated construction timelines and high costs, we foresee an exceptional opportunity for outsized growth and value creation in the coming years.
What went well
- Ventas delivered 10% total-company same-property cash NOI growth, led by 16% SHOP same-store NOI growth (18% in the U.S.), one of the strongest quarterly rates in recent history.
- Normalized FFO per share was $0.97, up 9% year-over-year, and the company again raised full-year normalized FFO guidance to $3.85-$3.90 (8-10% growth).
- SHOP same-store average occupancy rose 300 basis points year-over-year (360 bps in the U.S.), outperforming the NIC top-99 industry average by ~150 bps, with NOI margins up 210 bps to 31% and 55% incremental flow-through.
- The investment engine accelerated: full-year 2026 investment guidance was raised again from $3 billion to $4.5 billion, with over $8 billion of senior-housing investments (23,000+ units, 174 communities) completed since 2024.
- The balance sheet strengthened to net debt/EBITDA of 4.7x (mid-4s including unsettled equity), the best in over a decade, with $4.9 billion of liquidity.
- Highly occupied cohorts proved the growth runway: communities 90%+ occupied (about half the U.S. same-store portfolio) grew NOI 25% with 6% RevPOR, and the ~10% of communities at/near 100% occupancy grew NOI ~20% with 7% RevPOR.
What went wrong
- Net income attributable to common stockholders was only $0.14 per share, reflecting REIT depreciation despite strong FFO growth.
- The FFO guidance raise was modest (+$0.02 at the midpoint to $3.88), as ~$0.03 net from higher investment activity was partially offset by ~$0.01 from higher interest rates, a stronger dollar and a higher share price.
- Management held (did not raise) SHOP same-store NOI guidance at 16%, disappointing some investors given first-half strength, citing the key selling season still being in progress.
- The Research portfolio saw chunky occupancy loss from a few tenant non-renewals (a ~$900,000 year-over-year impact), expected to persist through the balance of the year.
- New development remains largely uneconomic, as current rents need to be ~25-40% higher to pencil at an ~8% development yield, limiting future supply (a long-term positive but near-term constraint).
Guidance Changes
| Metric | Period | Current guidance |
|---|---|---|
| Full-year normalized FFO per share | FY2026 | $3.85-$3.90 ($3.88 midpoint, +$0.02); 8-10% growth |
| Full-year net income per share | FY2026 | $0.58-$0.63 ($0.61 midpoint) |
| Full-year 2026 investments | FY2026 | $4.5 billion (senior-housing focused) |
| SHOP same-store NOI growth | FY2026 | 16% at midpoint (reaffirmed) |
| SHOP same-store occupancy growth | FY2026 | +300 bps |
| Full-year dispositions / loan repayments | FY2026 | ~$700 million (non-SHOP/non-strategic assets) |
| SHOP same-store operating expense growth | FY2026 | ~5.5% (volume-driven, with margin expansion) |
Performance Breakdown
| Metric | YoY | Note |
|---|---|---|
| Total-company same-store cash NOI | +10% | SHOP the primary driver with all other segments contributing double-digit same-store growth. |
| SHOP same-store cash NOI | +16% (U.S. +18%) | Occupancy up 300 bps (U.S. +360 bps) plus 5% RevPOR growth, with only 5% expense growth. |
| SHOP same-store revenue | ~+9% | Combination of occupancy and RevPOR growth, led by highly occupied communities. |
| SHOP NOI margin | +210 bps to 31% | Operating leverage as occupancy rises; 55% incremental flow-through. |
| Normalized FFO per share | $0.97 (+9%) | Strong property performance plus accretive senior-housing investment and 1-2-3 strategy execution. |
| Outpatient Medical & Research (OMAR) same-store cash NOI | +5% (outpatient medical +3% ex-fees) | 50 bps occupancy improvement and 88% tenant retention in outpatient medical. |
| Triple-net same-store cash NOI | +3% | Expected to accelerate in the second half. |
| 90%+ occupied U.S. cohort NOI | +25% (6% RevPOR) | Occupancy plus rate growth and margin expansion in about half the U.S. same-store portfolio. |
| Net debt / EBITDA | 4.7x (best in over a decade) | Organic growth plus equity-funded investments; 90 bps YoY / 30 bps sequential improvement. |
Earnings Call Themes & Trends
| Topic | Previous mention | Current period | Trend |
|---|---|---|---|
| Senior-housing demographic supercycle | 1-2-3 strategy adopted late 2023 | Leading edge of ~70 million baby boomers turning 80 (2 million in 2026 alone) doubles senior-population growth for a decade while new starts sit at record lows (~1,000 this quarter), setting up an exceptional multi-year NOI-growth and value-creation window. | — |
| SHOP investment engine / capital allocation | $3B 2026 target | Raised to $4.5B (over $8B since 2024); U.S. senior housing the #1 priority at mid-6% year-one yields and double-digit-to-mid-teens levered IRRs, funded via the accretive-and-deleveraging equity playbook; ~$1B under contract (two-thirds value-add) at ~6.5% yields. | — |
| Occupancy runway / stabilization thesis | 87% SHOP occupancy | Aiming to prove stabilization is far higher than historically assumed via a 'zero lost revenue days' culture; 90%+ cohort (25% NOI growth) and ~100% cohort (20% NOI growth, 7% RevPOR) demonstrate pricing power and margin expansion as occupancy climbs, with non-same-store only 83% occupied by design. | — |
| Portfolio recycling / dispositions | ~$500M normal disposition pace | Raising dispositions to ~$700M in the back half, focused on non-SHOP/non-strategic assets (including an 11%-yield loan repayment) as 'good hygiene' to improve the growth rate and push SHOP to 60% of the $60B enterprise by year-end. | — |
| Ventas OI operating platform | Active asset management build-out | Fully deployed across SHOP with data analytics, dynamic pricing, benchmarking and an AI-ready tech stack driving ~150 bps of occupancy outperformance versus industry; partnering with operators Atria, Sunrise (U.S.) and Le Groupe Maurice (Canada). | — |
| Development economics | Minimal new development | Development remains largely uneconomic (needs ~8% yield and trended rents ~25%+ higher, current ~6.5% investment yields); only disconnected luxury products may pencil, reinforcing the muted-supply thesis; Ventas stays focused on acquiring in-place cash flows. | — |
| Canada vs. U.S. RevPOR | — | Canada is 97% occupied with stable, rent-driven independent-living RevPOR under Quebec/Ontario rent restrictions (Le Groupe Maurice the standout); not viewed as the U.S. indicator, with U.S. upside instead shown by the 90%+ and ~100% occupied cohorts. | — |
| Non-same-store / Brookdale transitions | Low-occupancy transition assets | Non-same-store (~25% of SHOP NOI, 83% occupied) includes former Brookdale large-scale communities with operator changes, investment and re-leasing underway; management reaffirmed the opportunity to roughly double that NOI over time. | — |
Q&A Summary
Julien Blouin (Goldman Sachs) asked about recycling capital out of Outpatient Medical into senior housing and at what SHOP occupancy RevPOR accelerates.
Cafaro said Ventas will consider any value-creating transaction but is focused on expanding SHOP; Hutchens said the 90%+ occupied half of the U.S. same-store portfolio already runs 6% RevPOR and 25% NOI growth, illustrating a long runway from the current 87%.
Jeff Spector (Bank of America) asked about the monthly occupancy cadence and multi-year occupancy outlook.
Hutchens said Q1 delivered 310 bps and Q2 300 bps of growth, supporting the raised 300 bps full-year guide with good early key-selling-season activity, and reiterated proof points (90%+ cohort and the ~10% at/near 100% occupancy, two-thirds U.S.) that stabilization can reach ~100%.
David Rodgers (Raymond James) asked why SHOP flow-through jumped this year and about the development cycle.
Hutchens attributed the 55% incremental margin to higher occupancy fixing more costs (operating leverage), expecting further improvement over time, and said development is largely off the table (rents need to be ~25-40% higher) so Ventas focuses on acquiring in-place cash flows.
Seth Bergey (Citi) asked whether the deal funnel/close ratio and pricing have changed, and about back-half guidance conservatism.
Hutchens said cap rates drifted lower but Ventas holds steady mid-6% year-one yields and double-digit-to-mid-teens IRRs (the ~$1B under contract two-thirds value-add), winning more than its fair share; Probst bridged the raise as +$0.04 investments, -$0.01 dispositions, -$0.01 macro, implying ~$0.98 average back-half FFO.
Vikram Malhotra (Mizuho) asked why SHOP guidance was only held and about levers (Canada, medical office, life sciences) to lift FFO growth.
Hutchens noted the guide was already raised last quarter and execution lies ahead; Cafaro said the strategy is to drive same-property growth led by SHOP (fifth year of double-digit SHOP NOI) toward 60% of a $60B enterprise, with dispositions focused on non-SHOP assets and Canada remaining a significant contributor.
James Kammert (Evercore) asked how much of the 90%+ cohort's growth is pricing versus occupancy and about ~9% seller-retained interests.
Hutchens said the 90%+ group benefits from both occupancy and 6% RevPOR (7% in the ~100% cohort) as scarcity value builds, and explained the ~91% ownership reflects Ventas's share alongside its core-plus fund (Ventas takes ~20% of fund investments), plus one Revel JV.
Juan Sanabria (BMO) asked whether Canada RevPOR is a lead indicator for the U.S. and about the non-core dispositions/ScionHealth-Kindred loan.
Hutchens said Canada (97% occupied, rent-restricted Quebec/Ontario, stable independent-living RevPOR) is not a U.S. indicator, with U.S. upside shown by the highly occupied cohorts; Probst said the ~$700M dispositions are non-SHOP non-strategic assets including a ~$100M loan repaid at ~11%.
Michael Goldsmith (UBS) asked about Q3 investment activity yields/price-per-unit and the $300M healthcare loan.
Hutchens said three high-quality core-like communities (Colorado via the fund, plus California and Arizona) at ~6.2% yields and ~$554k/unit are market leaders in strong-demand markets, with the full $1B under contract expected at ~6.5%; Cafaro described the $300M loan as recycled capital in a well-structured position.
Michael Carroll (RBC) asked when the occupancy slope inflected this year and whether seasonality is normalizing.
Hutchens said the key selling season is always May-September with a strong pre-season start enabling the 270-to-300 bps raise, good early Q3 activity, and that seasonality persists but has been more muted outside the key season, possibly a new higher-demand paradigm.
Richard Anderson (Cantor) probed whether 'on track' hides any hiccups and whether the efficient occupancy frontier is below 100%.
Cafaro and Hutchens said there is nothing of concern with broad-based occupancy growth across products, operators and markets, and that the 'zero lost revenue days' commitment aims to get as many communities to 100% as possible given the lack of frictional vacancy and superior margin expansion at the top.
Jesus Garcia (Wells Fargo) asked whether acquisitions stay equity-funded and about the Brookdale transitions/doubling NOI.
Probst said the accretive-and-deleveraging equity-funding playbook (leverage now 4.7x, mid-4s including unsettled equity) will continue; Hutchens reaffirmed the opportunity to double the former-Brookdale non-same-store NOI as operator changes and investments take hold.
Omotayo Okusanya (Deutsche Bank) asked how Ventas thinks about large transformative SHOP transactions given peers getting bigger faster.
Cafaro said 'pressure is a privilege,' that Ventas has organized to capitalize on the multi-year opportunity, is building SHOP to 60% of a $60B enterprise with the investment engine firing and 16% SHOP NOI growth, and stays focused on outperformance at scale via disciplined strategy execution.
More on Ventas, Inc.
Reported 2026-07-30 · figures from the Ventas, Inc. Q2 2026 earnings call.
See how Top Bucket AI works for your firm
Request DemoTop Bucket AI Research
Stay ahead of private markets
Research and market intelligence for private-markets professionals.
✓
You're subscribed.
Thanks for signing up.